Immune Cell Dynamics in EGFR-Mutated NSCLC Treated With Afatinib and Pembrolizumab: Results From a Phase IB Study
阿法替尼和帕博利珠单抗治疗EGFR突变型非小细胞肺癌的免疫细胞动力学：一项IB期研究的结果
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2024.100706
Riess, Jonathan W; Lara, Matthew S; Lopez de Rodas, Miguel; Luxardi, Guillaume; Herbert, Samantha; Shimoda, Michiko; Kelly, Karen; Meerlev, Alexander; Moore, Elizabeth; Beckett, Laurel; Monjazeb, Arta; Schalper, Kurt; Maverakis, Emanual; Gandara, David R
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
免疫/内分泌
